Medivate Partners LLC is an investment arm of Posco specializing in cross border, growth capital, early stage and mid stage.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Jun 26, 2020
Artiva Biotherapeutics
|
Series A | $78M | Biotechnology | — |
Jan 22, 2020
Cognate BioServices
|
Series B | — | Biotechnology | — |
Jun 18, 2018
WindMIL Therapeutics
|
Series B | $32.50M | Biotechnology | — |
Feb 20, 2018
Cognate BioServices
|
Series Unknown | — | Biotechnology | — |
Mar 21, 2016
SillaJen
|
Series Unknown | $12M | Biotechnology | Yes |
Medivate Partners has had 2 exits. Medivate Partners most notable exits include Cognate BioServices , SillaJen
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
Feb 17, 2021 | Cognate BioServices | M&A | Biotechnology | Detail |
Dec 8, 2016 | SillaJen | IPO | Biotechnology | Detail |